Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on May 05, 2021 10:47am
104 Views
Post# 33131709

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:A little more information wouldn't be bad!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:A little more information wouldn't be bad!"Red I am sorry I do not understand your logic .  Rumour has it that already had a collaboration with Sanofi and a few other pharmas over the past few years. Nothing came from them even with great results"

I rest my case.  

It's comical to see you guys giving Philip a hard time for being a one man show yet implying Sanofi is focusing on cancer drugs.  With over 100,000 employees they will focus on all their R&D and anything that they see has potential.  If  Dr. Schulte, an internationally acclaimed expert in TD1 and RM suggests a collaboration might just happen and using it for their hemo can come out of the blue as could starting up TD1 again.  Pretending these massive companies momentum is static is a complete contradiction to the expectations for Philip to be dynamic.    
<< Previous
Bullboard Posts
Next >>